News | Contrast Media | July 17, 2017

ACR Offers Revised Contrast Media in Imaging Manual

Latest version offers new chapter on contrast-enhanced ultrasound, updates on patient selection and preparation strategies, and more

ACR Offers Revised Contrast Media in Imaging Manual

July 17, 2017 — The American College of Radiology (ACR) recently revised its authoritative guide for the safe and effective use of contrast media.

“Changes in technology and available scientific evidence prompted the updates in this practical reference,” said James H. Ellis, M.D., FACR, outgoing chair of the ACR Committee on Drugs and Contrast Media.

“The latest version of the manual incorporates multiple practical changes that immediately should improve the practice of radiology by groups who follow these guidelines,” said Matthew S. Davenport, M.D., FSAR, FSCBTMR, incoming chair.

The revised manual has updated chapters on:

  • Patient selection and preparation strategies;
  • Administering contrast media to pregnant or potentially pregnant patients;
  • Use of gadolinium-based contrast media in patients with normal and impaired renal function; and
  • There is also a new chapter addressing contrast-enhanced ultrasound.

The Manual on Contrast Media is available at no charge on the ACR website.

For more information: www.acr.org

Related Content

Iodine-based CT contrast with ready for scanning with a Canon Aquilion One 320-slice CT system at Northwestern Medicine Central DuPage Hospital in the Chicago suburbs. It is not clear that contrast caused contract induced nephrapathy (CIN), also referred to as acute kidney injury (AKI) or contrast-associated acute kidney injury (CAAKI),

Iodine-based CT contrast ready for scanning with a Canon Aquilion One 320-slice CT system at Northwestern Medicine Central DuPage Hospital in the Chicago suburbs.

Feature | Contrast Media | May 31, 2019 | Dave Fornell, Editor
Iodine-based contrast agents used in c
DyeMINISH Multi-center Global Patient Registry Launched
News | Contrast Media | May 09, 2019
Osprey Medical announced the launch of DyeMINISH, a global patient registry to evaluate the ongoing safety and...
VigiLanz and Cincinnati Children's Commercialize Real-Time Acute Kidney Injury Tracking
News | Contrast Media | November 30, 2018
VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration that leverages Cincinnati...
Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

News | Contrast Media | September 12, 2018
In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore co
Ligand Establishes Program to Develop Captisol-Enabled, Next-Generation Diagnostic Imaging Contrast Agents
News | Contrast Media | January 19, 2018
Ligand Pharmaceuticals Inc. announced initiation of a program to develop contrast agents with reduced renal toxicity....
FDA Holds MIDAC Meeting on Gadolinium-Based Contrast Agents. Image by Marilyn Fornell
News | Contrast Media | September 07, 2017
The U.S. Food and Drug Administration (FDA) announced it would hold a meeting of the Medical Imaging Drugs Advisory...
European Medicines Agency Issues Update on Gadolinium Contrast Agents
News | Contrast Media | August 29, 2017
August 29, 2017 — The European Medicines Agency (EMA) issued a final opinion that recommended restricting the use of
Guerbet Announces Plans to Streamline Contrast Media Portfolio, gadolinium MRI contrast
News | Contrast Media | July 18, 2017
Guerbet recently announced that it will phase out sales throughout the world of two products: Hexabrix (meglumine and...
Overlay Init